Zulieta, Aziz .
HRN: 24-88-81 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2024
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
04/23/2024
04/26/2024
PO
5ml
BID
Ascariasis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes